Sovereign Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Sell
3,975
-223
-5% -$48K 0.15% 123
2026
Q1
$913K Buy
4,198
+284
+7% +$63K 0.16% 124
2025
Q4
$894K Buy
3,914
+229
+6% +$52.2K 0.15% 122
2025
Q3
$853K Buy
3,685
+124
+3% +$25.3K 0.16% 121
2025
Q2
$661K Buy
3,561
+260
+8% +$48.3K 0.14% 134
2025
Q1
$692K Buy
3,301
+12
+0.4% +$2.33K 0.16% 117
2024
Q4
$585K Sell
3,289
-90
-3% -$16.5K 0.13% 140
2024
Q3
$667K Sell
3,379
-124
-4% -$23.1K 0.16% 123
2024
Q2
$601K Buy
3,503
+291
+9% +$48.2K 0.15% 129
2024
Q1
$585K Buy
3,212
+503
+19% +$86.7K 0.16% 128
2023
Q4
$420K Sell
2,709
-341
-11% -$49.7K 0.13% 157
2023
Q3
$455K Sell
3,050
-17
-0.6% -$2.5K 0.16% 131
2023
Q2
$413K Sell
3,067
-6
-0.2% -$880 0.13% 154
2023
Q1
$490K Buy
3,073
+11
+0.4% +$1.68K 0.18% 133
2022
Q4
$495K Buy
3,062
+1,444
+89% +$221K 0.19% 123
2022
Q3
$217K Sell
1,618
-12
-0.7% -$1.72K 0.09% 185
2022
Q2
$250K Sell
1,630
-21
-1% -$3.21K 0.1% 177
2022
Q1
$268K Buy
1,651
+20
+1% +$2.9K 0.1% 182
2021
Q4
$221K Buy
+1,631
New +$193K 0.09% 189

Other funds holding ABBV

Sovereign Financial Group's ABBV Position: Q2 2026 in Review

Sovereign Financial Group reduced its AbbVie (ABBV) stake by 5.3% in Q2 2026, selling an estimated $48K and leaving 3,975 shares worth $1M. The position accounts for 0.15% of the portfolio, ranked #123.

Sovereign Financial Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sovereign Financial Group held 3,975 shares of AbbVie worth $1M as of Q2 2026.
  • Sovereign Financial Group sold 223 AbbVie shares in Q2 2026, an estimated $48K.
  • AbbVie made up 0.15% of Sovereign Financial Group's portfolio in Q2 2026, its #123 holding.
  • Sovereign Financial Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sovereign Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.